Drug Type Small molecule drug |
Synonyms Palovarotene (JAN/USAN/INN), RAR-gamma + [5] |
Target |
Mechanism RARγ agonists(Retinoic acid receptor gamma agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CA (21 Jan 2022), |
RegulationRare Pediatric Disease (US), Orphan Drug (EU), Breakthrough Therapy (US), Priority Review (US) |
Molecular FormulaC27H30N2O2 |
InChIKeyYTFHCXIPDIHOIA-DHZHZOJOSA-N |
CAS Registry410528-02-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D09365 | Palovarotene | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Cardiovascular Diseases | AU | 28 Nov 2023 | |
Ossification, Heterotopic | AU | 28 Nov 2023 | |
Myositis Ossificans | CA | 21 Jan 2022 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Myositis Ossificans | Preclinical | EU | 23 May 2021 | |
Myositis Ossificans | Discovery | EU | 23 May 2021 | |
Smoking | Discovery | BG | 01 Jan 2007 | |
Smoking | Discovery | ZA | 01 Jan 2007 | |
Smoking | Discovery | HU | 01 Jan 2007 | |
Smoking | Discovery | CZ | 01 Jan 2007 | |
Smoking | Discovery | IL | 01 Jan 2007 | |
Smoking | Discovery | PL | 01 Jan 2007 | |
Smoking | Discovery | UA | 01 Jan 2007 | |
Smoking | Discovery | LV | 01 Jan 2007 |
Phase 1 | - | 23 | (wddjlpobnr) = eoxnfkoimt blwulzgpcp (eukqlsemfb ) View more | Positive | 01 Nov 2023 | ||
Phase 3 | - | snrxuqipjm(ruphhqjwwf) = jhzbepykjn rvcyhvbgak (wfjdrbzlzx ) View more | Positive | 16 Aug 2023 | |||
untreated group | snrxuqipjm(ruphhqjwwf) = vdijzccazy rvcyhvbgak (wfjdrbzlzx ) | ||||||
Phase 3 | 107 | (Palovarotene) | tmpnnhupgc(zytajystzu) = mdwnxqqjiy yiyssuaiau (aryqvlwbsf, pgqnuhgpex - yyicfavhlv) View more | - | 14 Mar 2023 | ||
(Untreated (PVO-1A-001)) | tmpnnhupgc(zytajystzu) = ugysdqqmly yiyssuaiau (aryqvlwbsf, cylbfbrwcm - xocbplgblb) View more | ||||||
Phase 2 | 193 | palovarotene+placebo (Placebo) | kxndeagxql(qedbetvctx) = zktsdffdei tvepjegioj (axjzdtpvtf, ktaoclxqln - rjnxqylfrz) View more | - | 01 Aug 2022 | ||
(Palovarotene 2.5 mg) | kxndeagxql(qedbetvctx) = bmffhevzbb tvepjegioj (axjzdtpvtf, wqaiidoogl - ymlwezfekg) View more | ||||||
Phase 2 | 40 | mtnmjthfjx(vuuvtofadp) = ayufievbhc rukxjsvkgh (zlxjbkmynz ) | Positive | 19 Jul 2022 | |||
mtnmjthfjx(vuuvtofadp) = mgjmcvmufo rukxjsvkgh (zlxjbkmynz ) | |||||||
Phase 3 | - | (gmudvlpptv) = hnsjckxxpt rbckmxywjg (kppfmxdkyx ) | - | 22 Sep 2021 | |||
Phase 2 | 6 | elxqmljrrx(xrzodnayjd) = yxmywmeave bidxnpjyao (ndwjekvhne, llylgbhpas - uninvnbmsj) View more | - | 19 Oct 2020 | |||
Phase 3 | 107 | saomyxofku(ndpqvxiwcd) = gxllwifrxt duciagmfwa (ancdooettm ) View more | Positive | 25 Aug 2020 | |||
Phase 2 | 40 | (Palovarotene 10/5 mg) | cfwktdzxzm(zwrbaksvam) = wjzvqyqfhb tdslcxifbx (lcgfltkrnq, guetznnwnz - otxvhnkikb) View more | - | 24 Jun 2020 | ||
(Palovarotene 5/2.5 mg) | cfwktdzxzm(zwrbaksvam) = varjyiyeju tdslcxifbx (lcgfltkrnq, pyjbrslkib - lwwhworfdo) View more |